REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,841 | +19.2% | 16,685 | +15.2% | 0.00% | 0.0% |
| Q2 2023 | $387,501 | +17.3% | 14,486 | -5.0% | 0.00% | 0.0% |
| Q1 2023 | $330,380 | +34.9% | 15,253 | +48.3% | 0.00% | +100.0% |
| Q4 2022 | $244,989 | +84.2% | 10,285 | +52.5% | 0.00% | 0.0% |
| Q3 2022 | $133,000 | +1.5% | 6,743 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | -23.8% | 6,743 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $172,000 | +1.2% | 6,743 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $170,000 | +23.2% | 6,743 | +34.9% | 0.00% | 0.0% |
| Q3 2021 | $138,000 | -13.2% | 4,999 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $159,000 | – | 4,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |